Older, critically ill patients with COVID-19 may have increased risk of bradycardia with lopinavir and ritonavir

The combined use of antiretroviral medications lopinavir and ritonavir, previously used to treat SARS-Cov-1 and MERS-Cov patients, appeared to cause bradycardia in 22% of elderly, critically ill COVID-19 patients, in a small study in France. Bradycardia was resolved in all patients after discontinuation or dose reduction of both medications.

About admin

Now Dr. Jack Straw is in charge of the website, and organizes it so that medical care is available to everyone. In addition, he is an active member of the medical community, regularly attending international conferences and sharing his experience and knowledge. Dr. Straw is not only a medical professional and website manager, but also a loving husband and father of his beautiful children.
View all posts by admin →

Leave a Reply

Your email address will not be published. Required fields are marked *